Early Medicare data on the Hospital at Home, the nonprofit caught in the Epic-particle antitrust fight, and more.

Chinese drugmakers targeted by forthcoming U.S. national security legislation are working on sales of some operations ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...

Opinion: Louisiana’s new restrictions on mifepristone and misoprostol threaten to negate the state’s recent gains in maternal ...

How Carequality navigates a conflict between Epic and Particle Health carries big implications for the future of health data ...

After demonstrating safety, the brain-computer interface field is now poised to leap from the lab to the real world.

Opinion: Universities can achieve their societal mission to advance knowledge and debate while protecting all voices through ...

U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird ...

As a cardiologist, I’ve seen first-hand the devastating toll heart failure takes on individuals and their loved ones. This significant and growing public health issue affects millions worldwide ...

The leading CPAP device maker's CEO sees 'two tidal waves' of innovation driving more people to the company's devices.

Earlier this year, STAT’s Eric Boodman reported the heartbreaking story of how, for decades, doctors have pressured sickle ...

A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients ...